文献速递心力衰竭与心肌病

射血分数保留型急性心衰亚表型的蛋白质组学与通路分析

Subphenogroups of acute heart failure with preserved ejection fraction: comprehensive proteomics and pathway analysis.
PubMed 文献 · Heart · 2026-04-10

本研究为PURSUIT-HFpEF前瞻性观察研究的post-hoc分析,对198例急性失代偿性HFpEF患者用机器学习聚类分为4个亚表型,用SomaScan检测>7000种血浆蛋白并做通路分析。结果显示各亚表型蛋白表达谱不同,免疫应答、自主神经激活、细胞稳态与组织修复通路存在差异。

要点

  • HFpEF可聚类为4个亚表型:节律障碍、心室-动脉脱耦联、低输出与系统性淤血、系统性衰竭。
  • 各亚表型血浆蛋白谱不同,核糖核酸酶4、TAX1BP1、REG3γ与α1-抗胰糜蛋白酶为最显著标志物。
  • 通路分析提示免疫应答、自主神经激活、细胞稳态与组织修复机制在各亚表型间存在差异。

核心结论

  • 基于 comprehensive 血浆蛋白质组学,HFpEF各亚表型具有不同的蛋白谱,提示其 underlying 生物学过程不同。
  • 炎症激活、组织损伤与再生反应、免疫调节及系统性应激信号可能是HFpEF病理生理的关键组成。

研究设计与样本

  • PURSUIT-HFpEF为多中心前瞻性观察研究,纳入住院急性失代偿性HFpEF患者,总队列N=1238。
  • 本分析纳入198例有蛋白质组学数据的HFpEF患者,用机器学习聚类模型分为4个亚表型。
  • 用SomaScan assay V.4.1检测>7000种血浆蛋白水平,并进行通路分析。

主要发现

  • 识别出4个亚表型:表型1「节律障碍」、表型2「心室-动脉脱耦联」、表型3「低输出与系统性淤血」、表型4「系统性衰竭」。
  • 核糖核酸酶4、tax1结合蛋白1、再生胰岛衍生蛋白3-γ与α1-抗胰糜蛋白酶为各亚表型最显著的标志物。
  • 通路分析提示各亚表型在免疫应答、自主神经激活、细胞稳态与组织修复机制上存在差异。

临床怎么用

  • 对急性失代偿性HFpEF患者可考虑基于蛋白质组学的亚表型划分,以辅助识别不同生物学通路。
  • 亚表型对应的免疫、自主神经、细胞稳态与组织修复通路差异,可能为个体化治疗策略提供线索。

局限性

  • 本研究为post-hoc分析,仅198例有蛋白质组学数据的患者纳入分析。
  • 原文未报告亚表型聚类模型的具体算法与验证细节。
  • 原文未报告各亚表型的临床结局比较数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heterogeneity of heart failure with preserved ejection fraction (HFpEF) results in significant challenges for treatment development. Identifying and characterising distinct HFpEF phenogroups may aid in tailoring therapeutic strategies for these patients. The objective of this study was to assess proteomic patterns of HFpEF phenogroups identified through a machine-learning-based clustering model, with the aim of uncovering specific biological pathways associated with each phenogroup. METHODS: This study represents a post-hoc analysis of the ongoing Prospective mUlticenteR obServational stUdy of patIenTs with Heart Failure with preserved Ejection Fraction (PURSUIT-HFpEF) study, which is a multicentre prospective observational study of hospitalised patients with acute decompensated HFpEF. Of the overall cohort (N=1238), this study analysed 198 patients with HFpEF with available proteomics data. These patients were classified into four phenogroups using the machine-learning-based clustering model. The SomaScan assay V.4.1 was used to measure levels of >7000 plasma proteins, and subsequent pathway analysis was conducted to determine the biological differences among the phenogroups. RESULTS: We identified four distinct phenogroups: Phenogroup 1 ('rhythm trouble'), Phenogroup 2 ('ventricular-arterial uncoupling'), Phenogroup 3 ('low output and systemic congestion') and Phenogroup 4 ('systemic failure'). The proteomics revealed distinct protein expression profiles among the phenogroups, with ribonuclease 4, tax1-binding protein 1, regenerating islet-derived protein 3-gamma and alpha-1-antichymotrypsin being the most significant markers to specific identified phenogroups. Pathway analysis suggested differences in immune response, autonomic activation, cellular homeostasis and tissue repair mechanisms across the phenogroups. CONCLUSIONS: Using a comprehensive plasma proteomics approach, our study identified distinct proteomic profiles of HFpEF phenogroups, which in turn suggest specific underlying biological processes. These profiles suggest the involvement of inflammatory activation, tissue injury and regenerative responses, immune modulation and systemic stress signalling as key components of HFpEF pathophysiology. TRIAL REGISTRATION NUMBER: UMIN-CTR ID: UMIN000021831.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Sotomi, Matsuoka, Ebert, et al. Subphenogroups of acute heart failure with preserved ejection fraction: comprehensive proteomics and pathway analysis. Heart. 2026. PMID: 40750341. doi:10.1136/heartjnl-2025-326091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。